- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07928557
The Effects of Tai Chi in Individuals With Multiple Sclerosis
The Effects of Tai Chi on Executive Functions in Individuals With Multiple Sclerosis: A Randomized Controlled Trial
This study aimed to evaluate the effects of Tai Chi exercise on cognitive functions, fatigue, and depressive symptoms in individuals with Multiple Sclerosis (MS). MS is a chronic neurological disease characterized by demyelination within the central nervous system and is frequently associated with cognitive, physical, and psychological impairments.
Individuals diagnosed with MS were assigned to either an 8-week Tai Chi exercise program or a home-based Frenkel exercise program. Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which comprises the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test-II (CVLT-II), and Brief Visuospatial Memory Test-Revised (BVMT-R). Fatigue was evaluated using the Fatigue Impact Scale (FIS), while depressive symptoms were assessed using the Beck Depression Inventory (BDI).
The study aimed to investigate the effects of Tai Chi exercise compared with a home-based exercise program on cognitive performance, fatigue, and depressive symptoms in individuals with MS. The findings may contribute to the evidence base for non-pharmacological rehabilitation approaches in MS management.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Multiple Sclerosis (MS) is a chronic, immune-mediated neurological disease characterized by inflammation, demyelination, and neurodegeneration within the central nervous system. Cognitive impairment, fatigue, and depression are among the most common and disabling symptoms in individuals with MS, significantly affecting their quality of life. In addition to pharmacological treatments, exercise-based rehabilitation approaches have gained increasing attention in recent years.
This randomized controlled study investigated the effects of a structured Tai Chi exercise program on cognitive functions, fatigue, and depressive symptoms in individuals with MS. Participants diagnosed with MS were randomly allocated to either a Tai Chi intervention group or an active control group receiving a home-based Frenkel exercise program. Both groups continued their standard medical care throughout the study.
The Tai Chi intervention was conducted over 8 weeks, with two supervised sessions per week. Each session lasted approximately 50 minutes and included warm-up exercises, Tai Chi practice, and cool-down activities.
Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which comprises three tests: the Symbol Digit Modalities Test (SDMT), assessing information processing speed; the California Verbal Learning Test-II (CVLT-II), assessing verbal learning and memory; and the Brief Visuospatial Memory Test-Revised (BVMT-R), assessing visuospatial learning and memory. Fatigue was evaluated using the Fatigue Impact Scale (FIS), while depressive symptoms were assessed using the Beck Depression Inventory (BDI).
The primary outcome was cognitive performance following the intervention, while secondary outcomes included changes in fatigue and depressive symptoms. All outcome measures were assessed at baseline and after the 8-week intervention period.
This study aimed to contribute to the evidence regarding the potential role of Tai Chi as a non-pharmacological rehabilitation approach for managing cognitive and psychological symptoms in individuals with MS.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Denizli
-
Denizli, Denizli, Turkiet (Türkiye), 20000
- Pamukkale University
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Diagnosis of multiple sclerosis (MS) according to the McDonald criteria.
- Relapsing-remitting multiple sclerosis (RRMS) phenotype.
- Age between 20 and 60 years.
- Willingness to participate in the study.
- Expanded Disability Status Scale (EDSS) score ≤3.5.
Exclusion Criteria:
- Use of medications that could affect clinical assessment or cognitive test performance, including antipsychotic medications or continuous corticosteroid or immunosuppressive therapy within the preceding month.
- Presence of additional neurological, psychiatric, or systemic diseases that could affect clinical or cognitive assessments.
- Participation in another structured exercise program.
- Experiencing an MS relapse within the preceding four weeks.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Tai Chi Intervention Group
Participants received an 8-week Tai Chi intervention program designed for individuals with Multiple Sclerosis. The program included coordinated body movements, breathing control, and mindful movement practice, aiming to improve cognitive function, reduce fatigue, and improve depression levels in individuals with MS. The program consisted of progressively taught 8 movements selected from the basic 10 Yang-style forms, focusing on controlled weight shifting, postural alignment, and whole-body coordination. Each session consisted of a warm-up phase with general stretching exercises, a main Tai Chi practice component with form repetition and rest breaks as needed, and a cool-down phase including stretching and controlled breathing exercises. |
Tai Chi was administered for 8 weeks, 2 days per week, for a total of 16 sessions. Each session lasted approximately 50 minutes and included warm-up stretching exercises (10 minutes), Tai Chi practice (30 minutes), and cool-down exercises (10 minutes). Sessions were conducted in groups of 2-3 participants under physiotherapist supervision. |
|
Aktiv komparator: Home Exercises Group
Participants in this group received an 8-week home exercise program consisting of Frenkel coordination exercises. They were instructed to perform the prescribed exercises independently at home throughout the study period. Participants did not participate in the Tai Chi intervention. The program served as an active comparator for evaluating the effects of Tai Chi on cognitive function, fatigue, and depression in individuals with MS. |
Participants performed a home-based Frenkel exercise program for 8 weeks, twice weekly. Each session lasted approximately 15-30 minutes, excluding rest periods. Participants received an instructional booklet and an exercise logbook to record their exercise sessions. Adherence was monitored through telephone follow-up calls every two weeks. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Cognitive functions assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
Tidsram: Baseline and 8 weeks after the intervention
|
Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which includes the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test-II (CVLT-II), and Brief Visuospatial Memory Test-Revised (BVMT-R). |
Baseline and 8 weeks after the intervention
|
|
Symbol Digit Modalities Test (SDMT)
Tidsram: Baseline and 8 weeks after the intervention.
|
Information processing speed was assessed using the Symbol Digit Modalities Test (SDMT). Higher scores indicate better cognitive performance |
Baseline and 8 weeks after the intervention.
|
|
California Verbal Learning Test-II (CVLT-II)
Tidsram: Baseline and 8 weeks after the intervention.
|
Verbal learning and memory were assessed using the California Verbal Learning Test-II (CVLT-II). Higher scores indicate better verbal learning and memory performance. |
Baseline and 8 weeks after the intervention.
|
|
Brief Visuospatial Memory Test-Revised (BVMT-R)
Tidsram: Baseline and 8 weeks after the intervention.
|
Visuospatial learning and memory were assessed using the Brief Visuospatial Memory Test-Revised (BVMT-R). Higher scores indicate better visuospatial learning and memory performance. |
Baseline and 8 weeks after the intervention.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Fatigue Impact Scale (FIS) score
Tidsram: Baseline and 8 weeks after the intervention
|
The impact of fatigue on physical, cognitive, and social functioning was assessed using the Fatigue Impact Scale (FIS). Lower scores indicate less fatigue-related impact. |
Baseline and 8 weeks after the intervention
|
|
Beck Depression Inventory (BDI) score
Tidsram: Baseline and 8 weeks after the intervention
|
Depressive symptoms were assessed using the Beck Depression Inventory (BDI). Lower scores indicate fewer depressive symptoms. |
Baseline and 8 weeks after the intervention
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Sjukdomar i nervsystemet
- Autoimmuna sjukdomar
- Immunsystemets sjukdomar
- Beteendesymtom
- Demyeliniserande autoimmuna sjukdomar, CNS
- Autoimmuna sjukdomar i nervsystemet
- Demyeliniserande sjukdomar
- Patologiska tillstånd, tecken och symtom
- Beteende
- Tecken och symtom
- Multipel skleros
- Depression
- Trötthet
- Multipel skleros, skov-remitterande
Andra studie-ID-nummer
- E-60116787-020-237275
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .